Restless Leg Syndrome Associated with Olanzapine: A Case Series

被引：24
作者：
Aggarwal, Shilpa [1 ,5 ]
Dodd, Seetal [1 ,2 ]
Berk, Michael [1 ,2 ,3 ,4 ]
机构：
[1] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia
[2] Barwon Hlth, Geelong, Vic, Australia
[3] Orygen Res Ctr, Parkville, Vic, Australia
[4] Mental Hlth Res Inst, Parkville, Vic, Australia
[5] Royal Childrens Hosp, Melbourne, Vic, Australia
来源：
CURRENT DRUG SAFETY | 2010年 / 5卷 / 02期
关键词：
Restless legs syndrome; olanzapine;
D O I：
10.2174/157488610790936187
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Restless leg syndrome (RLS) is a common disorder associated with significant distress. We report three cases of drug induced RLS caused by olanzapine. In each case, RLS commenced after initiation of treatment with olanzapine and resolved after ceasing olanzapine. All three patients were subsequently treated with other atypical antipsychotics, risperidone, quetiapine or aripiprazole, without re-emergence of RLS. RLS is associated with central dopaminergic dysfunction. Dopamine agonists and l-dopa reduce the symptoms of RLS, and some agents that block the dopaminergic system aggravate RLS. Greater awareness of potential causes of RLS, and its differentiation from akathisia and illness related agitation might help in reducing the distress associated with it and improving patient compliance.
引用
收藏
页码：129 / 131
页数：3
相关论文
共 33 条
  • [1] Restless legs syndrome induced by mirtazapine
    Agargün, MY
    Kara, H
    Özbek, H
    Tombul, T
    Ozer, OA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (12) : 1179 - 1179
  • [2] Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome
    Allen, R
    Becker, PM
    Bogan, R
    Schmidt, M
    Kushida, CA
    Fry, JM
    Poceta, JS
    Winslow, D
    [J]. SLEEP, 2004, 27 (05) : 907 - 914
  • [3] [Anonymous], 2000, DIAGNOSTIC STAT MANU
  • [4] Bogan R, 2005, MOVEMENT DISORD, V20, pS61
  • [5] Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: Epidemiological survey in Sweden
    Broman, Jan-Erik
    Mallon, Lena
    Hetta, Jerker
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 62 (04) : 472 - 475
  • [6] Support for dopaminergic hypoactivity in restless legs syndrome:: a PET study on D2-receptor binding
    Cervenka, Simon
    Palhagen, Sven E.
    Comley, Robert A.
    Panagiotidis, Georgios
    Cselenyi, Zsolt
    Matthews, Julian C.
    Lai, Robert Y.
    Halldin, Christer
    Farde, Lars
    [J]. BRAIN, 2006, 129 : 2017 - 2028
  • [7] Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang, CC
    Shiah, IS
    Chang, HA
    Mao, WC
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (02) : 316 - 318
  • [8] PERIODIC MOVEMENTS IN SLEEP NOCTURNAL MYOCLONUS - RELATION TO SLEEP DISORDERS
    COLEMAN, RM
    POLLAK, CP
    WEITZMAN, ED
    [J]. ANNALS OF NEUROLOGY, 1980, 8 (04) : 416 - 421
  • [9] Clozapine-associated restless legs syndrome
    Duggal, Harpreet S.
    Mendhekar, Dattatreya N.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (01) : 89 - 90
  • [10] Earley CJ, 2001, MOVEMENT DISORD, V16, P144, DOI 10.1002/1531-8257(200101)16:1<144::AID-MDS1009>3.0.CO
1234